Search Ontology:
ChEBI
daclatasvir hydrochloride
- Term ID
- CHEBI:83800
- Synonyms
-
- BMS 790052-05
- BMS-790052-05
- Daclatasvir dihydrochloride
- Daklinza
- Dimethyl N,N'-(biphenyl-4,4'-diylbis(1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)))dicarbamate dihydrochloride
- methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride
- Definition
- A hydrochloride obtained by combining daclatasvir with two molar equivalents of hydrochloric acid. It is a potent inhibitor of nonstructural protein 5A and is used for treatment of hepatitis C.
- References
-
- CAS:1009119-65-6
- KEGG:D10105
- PMID:25117197
- Reaxys:13072109
- Wikipedia:Daclatasvir
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_part
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from daclatasvir hydrochloride
Phenotype where environments contain daclatasvir hydrochloride
Phenotype modified by environments containing daclatasvir hydrochloride
Human Disease Model